Validation Guidance for Residual Host Cell DNA Testing of Biologics

Watch Now

Sign Up:

First Name *

* Required

Last Name *

* Required

Job Title *

* Required

Company *

* Required

Address *

* Required

City *

* Required

State *

* Required

Post Code or Zip *

* Required

Country *

* Required

Email *

* Required

Work Phone *

* Required

Would you like to receive more content from American Pharmaceutical Review? Please select below *

The resDNASEQ Quantitative DNA Kit is a qPCR-based system for the detection of host-cell DNA from various cell lines (CHO, HEK293, Human, E. coli, Vero, MDCK, Pichia Pastoris, NS0, and more). Would you like a Thermo Fisher technical expert to contact you (by email or telephone) to learn more about resDNASEQ Quantitative DNA Kit?

Yes, I would like a Thermo Fisher Scientific Rep to contact me. * Required

By submitting my personal data, to CompareNetworks, I acknowledge it will be shared with the Thermo Fisher Scientific group for processing in accordance with the Thermo Fisher Scientific Privacy Policy.
Yes, I agree for the Thermo Fisher Scientific group to contact me by e-mail and telephone to inform me of events, products, services and promotions offered in connection which they believe may be of interest to me. I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com.

I agree * Required

The webinar sponsor and CompareNetworks may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Overview

Assurance of product safety and quality are top of mind for all biotherapeutic manufacturers. A variety of analytical assays are implemented for this purpose. Some are presence/absence only to detect microbial contamination, such as bacterial or viral. Others are quantitative, to measure the amount of impurities, such as host-cell protein or host-cell residual DNA.

QC methods using these assays require validation per International Conference on Harmonization guidelines, ICH Q2(R1), ‘Validation of Analytical Procedures’, to ensure that the analytical procedure is suitable for intended use in assessing the quality and reliability of analytical test results.

In this presentation, we will discuss the components of a method validation per ICH Q2(R1) in the context of a quantitative polymerase chain reaction (PCR) assay for sensitive, accurate and rapid quantitation of residual DNA from a variety of host-cell systems, including Chinese Hamster Ovary (CHO), E. coli, Vero and Human/Human Embryonic Kidney 293 (HEK293).

In this webinar you’ll learn:

• Key things to consider when establishing acceptance criteria

• Overview of how to design validation studies

• Review of data from validation of a qPCR assay for residual host cell DNA quantitation

Who should attend:

• Process Development Scientist

• Analytical Development Scientist

• Quality Control, Quality Assurance Scientist,

• Regulatory/CMC Managers

Presenters

Mike Brewer

(Presenter)
Director, Global Principal Consultant, Regulatory,
Thermo Fisher Scientific
View Biography

Mike Auerbach

(Moderator)
Editor-in-Chief,
American Pharmaceutical Review